US › Healthcare

Bone Biologics Corp (BBLG)

US · Healthcare · Biotechnology

$0.40+1.80%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-773,702

EPS

$-0.43

EPS estimate

$-0.39

EPS came in at -0.43 against a street estimate of -0.39 — a miss of 10.3%.

Key statistics

Market cap

$1.1M

Forward P/E

0.0

P/B

0.36

Book value

$2.17

EPS (TTM)

$-1.37

52-week high

$2.60

52-week low

$0.38

50-day MA

$0.56

200-day MA

$1.12

Beta

0.57

Analyst view

with an average price target of $12.20.

Shareholding

Insiders

0.02%

Institutions

5.01%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.19%
Tower Research Capital LLC	0.10%
SBI Securities Co Ltd	0.01%
DRW Securities, LLC	0.00%
Two Sigma Investments LLC	0.00%
Bank of America Corp	0.00%
UBS Group AG	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bone Biologics Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.